Literature DB >> 1651204

Biology of female sex hormone action in relation to contraceptive agents and neoplasia.

R J King1.   

Abstract

This article will present an overview of estrogen and progestin action at a cellular level, with emphasis on points that are relevant to neoplasia. In breast, endometrium and ovary, these two classes of hormone are clearly implicated in carcinogenesis, but their involvement with cancers of the liver, cervix and other tissues is more problematic. In the latter situations, I will highlight the major points to be considered if the hormones are involved without wishing to judge whether there actually is a causal involvement.

Entities:  

Keywords:  Adrenal Cortex Hormones; Androgens; Biological Characteristics; Biology; Breast Cancer--etiology; Cancer; Cervical Cancer--etiology; Cervical Effects; Cervix; Child Development; Contraception; Contraceptive Agents, Estrogen--pharmacodynamics; Contraceptive Agents, Female--pharmacodynamics; Contraceptive Agents, Progestin--pharmacodynamics; Contraceptive Agents--pharmacodynamics; Corpus Luteum Hormones; Cytology; Diseases; Endocrine Effects; Endocrine System; Endometrial Cancer--etiology; Endometrial Effects; Endometrium; Estrogens; Family Planning; Genitalia; Genitalia, Female; Growth; Hormone Receptors; Hormones; Literature Review; Mammary Gland Effects; Membrane Proteins; Neoplasms; Ovarian Cancer--etiology; Ovarian Effects; Ovary; Physiology; Urogenital System; Uterus

Mesh:

Substances:

Year:  1991        PMID: 1651204     DOI: 10.1016/0010-7824(91)90002-w

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  5 in total

1.  Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop.

Authors:  E van Garderen; M de Wit; W F Voorhout; G R Rutteman; J A Mol; H Nederbragt; W Misdorp
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

2.  Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006.

Authors:  Tsogzolmaa Dorjgochoo; Xiao-Ou Shu; Hong-Lan Li; Han-Zhu Qian; Gong Yang; Hui Cai; Yu-Tang Gao; Wei Zheng
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

3.  Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.

Authors:  Ting Liu; Lilan Chen; Xiangjun Sun; You Wang; Shu Li; Xia Yin; Xinran Wang; Chenhuan Ding; He Li; Wen Di
Journal:  Tumour Biol       Date:  2013-11-07

4.  Growth hormone mRNA in mammary gland tumors of dogs and cats.

Authors:  J A Mol; E van Garderen; P J Selman; J Wolfswinkel; A Rijinberk; G R Rutteman
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 5.  Contraceptive steroids and the mammary gland: is there a hazard?--Insights from animal studies.

Authors:  G R Rutteman
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.